“…High plasma levels of lipoprotein (a) are associated with thin-cap fibro-atheroma and a worse prognosis in patients with CAD [2] . In the attempt to identify non-invasive surrogate biomarkers for lipid burden in coronary plaques, Sæther et al reported that serum levels of lipoprotein (a) and free cholesterol in the smallest HDL sub-fractions have the strongest potential as predictors for lipid content in coronary atheromatous plaques [3] . In recent years, the research ofCAD has focused on the potential contribution of the immune system.…”